Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: migraine  suffers  medical  visits  headache  physicians  patients  survey  harris  interactive  nhf  multivu  48956  medicine  family  safety  health  pharmaceuticals  teeth  children  cold  probiotics  multivu  8134881  national  pharmacy  prescription  drug  program  medco  foundation  dispensary  of  hope  clinics  medication  uninsured  low  income  health  medication  lawsuit  money  astellas  pharma  prograf  money  refund  healthcare  multivu  7933851  drugs  cost  medication  medical  health  money  prices  saving  multivu  8478051  fda  bph  benign  prostatic  hyperplasia  men  treatment  rezum  health  prostate  nxthera  multivu  7933151  safety  safe  storage  safe  dosing  safe  kids  safe  medication  child  poisoning  deaths  parents  caregivers  multivu  55155  parkinsons  disease  zambon  xadago  safinamide  treatment  european  union  chmp  medication  medicine  multivu  7406951  science  abbott  technology  health  treatment  healthcare  medication  new  breakthrough  multivu  7962251  small  bowel  recipient  chief  mcneel  small  intestine  transplant  health  georgetown  treatments  multivu  52073  constipation  remedies  constipation  constipation  relief  constipation  cure  cat  flea  treatment  cat  flea  dog  flea  treatment 
Search // medication
Results 49-59 of 59 for ' medication ' (0 seconds)
CVS Health (NYSE:CVS), the nation’s largest pharmacy innovation company, today announced Be The First, a five-year $50 million initiative to help deliver the nation’s first tobacco-free generation. Through this initiative, which is funded through CVS Health and the CVS Health Foundation, the company is extending its commitment to help people lead tobacco-free lives. Recognizing that tobacco use is the leading preventable cause of disease and death in the United States and that youth use of some tobacco products is on the rise, Be The First comprises comprehensive education, advocacy, tobacco control and healthy behavior programming in partnership with organizations uniquely positioned to tackle this public health challenge. “We are at a critical moment in our nation’s efforts to end the epidemic of tobacco use that continues to kill more people than any other preventable cause of death, and threatens the health and well-being of our next generation,” said Troyen A. Brennan, M.D., M.P.H., and Chief Medical Officer for CVS Health. “Ensuring our youth stay tobacco-free requires increased education and awareness of healthy behaviors. We’re partnering with experts across the public health community who have established best practices to help prevent tobacco use. And, by establishing more public-private partnerships to implement these strategies more aggressively, we can help increase the number of people leading tobacco-free lives and move us one step closer to delivering the first tobacco-free generation.” To view the multimedia release go to: http://www.multivu.com/players/English/7775151-cvs-health-be-the-first/
Categories // Miscellaneous 
Added: 3208 days ago by MultiVuVideos
Runtime: 1m10s | Views: 738 | Comments: 0
Not yet rated
 

 

 

Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the COMPACT study, a pivotal Phase III study evaluating the safety and efficacy of CSL830 (a novel, investigational, self-administered, subcutaneous C1-Esterase Inhibitor [C1-INH] Human replacement therapy) for the prevention of HAE attacks. The study met its primary efficacy endpoint, significantly reducing the time-normalized number of HAE attacks. In addition, the study met its secondary endpoints, including the responder rate (patients who had at least a 50% reduction in their attack rate) and the number of rescue medication uses. If approved by the FDA, CSL830 would be the first and only subcutaneous preventative therapy for HAE. To view the multimedia release go to: https://www.multivu.com/players/English/8056151-csl-behring-subcutaneous-c1-esterase-inhibitor-hae-patients/
Categories // Miscellaneous 
Added: 2830 days ago by MultiVuVideos
Runtime: 2m41s | Views: 678 | Comments: 0
Not yet rated
 

 

 

CareFusion today launched the Pyxis® Enterprise System (ES) platform, a new generation of its industry-leading automated dispensing systems that will enable hospital customers to simplify and standardize the medication management process, both within a single facility and across an entire health system. The new CareFusion Pyxis hardware and software brings key benefits to pharmacy, nursing and information technology (IT) departments. To view Multimedia News Release, go to http://www.multivu.com/mnr/53365-carefusion-unveils-pyxis-automated-medication-dispensing-system
Categories // Science and Technology 
Added: 4762 days ago by MultiVuVideos
Runtime: 1m44s | Views: 5672 | Comments: 0
Not yet rated
 

 

 

Janssen Healthcare Innovation, a team within Janssen Research & Development, LLC focusing on optimizing healthcare delivery, announced today the launch of Care4Today™ Mobile Health Manager 2.0 (mhm.care4today.com). This free mobile platform and website is designed to help people stay on schedule with their medications with special features such as Care4Family™ and Care4Charity™ to support and motivate users to take their medications regularly. To view Multimedia News Release, go to http://www.multivu.com/mnr/62572-janssen-healthcare-innovation-launches-care4today-mobile-health-manager
Categories // Business  Science and Technology 
Added: 4105 days ago by MultiVuVideos
Runtime: 3m29s | Views: 1781 | Comments: 1
Not yet rated
 

 

 

Blink Health, America’s leading prescription drug savings platform, today launched a program to help #TreatType2 diabetes by committing to give away $10 million worth of medication to patients with type-2 diabetes. People living with diabetes who create an account on Blink Health’s website or free mobile app, starting today, will receive a free, one-year supply of the three most commonly prescribed generic medications for type-2 diabetes: metformin, glipizide and pioglitazone. The program will also cover these three medications for existing Blink Health patients who use them. To view the multimedia release go to: https://www.multivu.com/players/English/8117451-blink-health-type-2-diabetes-medications/
Categories // Miscellaneous 
Added: 2753 days ago by MultiVuVideos
Runtime: 0m15s | Views: 521 | Comments: 0
Not yet rated
 

 

 

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its latest advancement in comprehensive medication management, BD HealthSight™ platform for enterprise medication management, which offers a unique combination of connective technologies, analytics and expert services at this year's American Society of Health-System Pharmacists (ASHP) 2017 Midyear Meeting being held in Orlando from Dec. 3-7. With direct medical costs associated with medication errors reaching $21 billion worldwide, innovative strategies must be developed to address the grand health challenges associated with medication management. BD has been evolving its focus to re-invent medication management with integration of the company’s technologies, analytics and expert services that aim to close the communication gaps across disparate solutions. The BD HealthSight platform connects systems and processes to help hospitals and health systems drive a safer, more efficient medication management process. To view the multimedia release go to: https://www.multivu.com/players/English/8198551-bd-healthsight-platform-ashp-2017/
Categories // Miscellaneous 
Added: 2592 days ago by MultiVuVideos
Runtime: 2m24s | Views: 658 | Comments: 2
Not yet rated
 

 

 

More than 15 percent of reproductive-aged women have filled a prescription for an antidepressant medication during the years 2008–2013, according to a new analysis published today in the Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report (MMWR). January is National Birth Defects Prevention Month and the CDC is working with the March of Dimes to raise awareness about the use of antidepressant medications by women of reproductive age, and what women should know and do for their own health and that of their babies. There is conflicting evidence about the potential link between some antidepressants and certain birth defects. Some commonly used antidepressants are sertraline (Zoloft), bupropion (Wellbutrin, Zyban), and citalopram (Celexa). To view the multimedia release go to: http://www.multivu.com/players/English/7709851-march-of-dimes-antidepressant-pregnancy-study/
Categories // Miscellaneous 
Added: 3250 days ago by MultiVuVideos
Runtime: 1m31s | Views: 816 | Comments: 0
Not yet rated
 

 

 

http://adultadhdtreatmentblog.com/adult-ritalin-is-this-effective-for-adult-adhd/ Occasionally trying to find an perfect grownup ADHD treatments and adult ritalin is really a seemingly endless array of medical medical doctors visits, medication modifications, and dosage adjustments. I understand your aggravation and share your discomfort. Nevertheless, existence will go on, so we must pick ourselves up and get back concerning the bus in make an effort to find that 1 grownup ADHD treatments that will assist us overcome those problematic grownup ADHD symptoms that may happen to be dogging us for years, for example inattention, impulsive behavior, and restlessness. Whilst this list won’t provide you with a brand new prescription drug alternative, it just might help you to improve your outcomes and minimize people pesky side effects. There
Tags // adult  ritalin  breaking  news  featured  news  adult  adhd 
Categories // People and Blog 
Added: 5263 days ago by frankwyatt77
Runtime: 0m52s | Views: 4459 | Comments: 0
Not yet rated
 

 

 

The thinking that diet does not affect acne is a falsehood perpetuated by that part of the medical industry that is trying to protect their livelihood of dispensing drugs. The AMA has established that the only way to deal with acne is through the use of medication. They say there is no evidence to support the idea that diet causes acne.
Categories // Family 
Added: 1602 days ago by rss41
Runtime: 4m37s | Views: 713 | Comments: 0
Not yet rated
 

 

 

With the ultimate goal of preventing half a million teens from abusing medicine within five years, The Partnership at Drugfree.org will launch The Medicine Abuse Project during the week of September 23-29, 2012. The launch week will kick start a multi-year effort to help educate parents, teens and the public about the dangers of medicine abuse and unite parents, educators, health care providers, coaches, government officials, law enforcement officers and other partners to help save lives. To view Multimedia News Release, go to http://www.multivu.com/mnr/54143-the-partnership-at-drugfree-org-medicine-abuse-project-teen-education
Categories // People and Blog 
Added: 4471 days ago by MultiVuVideos
Runtime: 1m34s | Views: 1607 | Comments: 0
Not yet rated
 

 

 

(RED) today announced the launch of The Lazarus Effect Campaign, a multi-platform campaign across TV, online and print, including an HBO documentary airing on May 24, that will help raise awareness of the transformative effect of antiretroviral medicine for those living with HIV in Africa. Launching April 29 on HBO, the awareness campaign will roll out across various TV and online networks in the coming weeks. The campaign equates the relative value of 40 cents by comparing trivial items worth 40 cents e.g. a stick of gum, a smear of lipstick — to the value of one day\'s worth of life transforming antiretroviral medication./nTo view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/red/43843/
Categories // People and Blog 
Added: 5349 days ago by MultiVuVideos
Runtime: 1m2s | Views: 7613 | Comments: 1
     
 

 

 

Page 5 of 5  |  Go to page     |  ««FIRST «Previous  



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.